Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose‐seeking study

Background. Treatment of the symptoms of bone metastases currently involves the use of narcotic medication, radiation therapy, or hormonal therapy. Pamidronate disodium, a bisphosphonate, may prove helpful in the palliative treatment of bone metastases in patients with breast cancer as demonstrated in this multicenter, dose‐ranging trial.

[1]  K. Foley.  Pain syndromes in patients with cancer. , 1987, The Medical clinics of North America.

[2]  A. Johnston.  Pathology of Metastatic Tumors in Bone , 1970, Clinical orthopaedics and related research.

[3]  A. Howell,et al.  Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy , 1988, British medical journal.

[4]  P. Woll,et al.  Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). , 1988, British Journal of Cancer.

[5]  C. Galasko,et al.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins , 1976, Nature.

[6]  D. Tong,et al.  The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group , 1982, Cancer.

[7]  O. Bijvoet,et al.  INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.) , 1979, The Lancet.

[8]  A. Howell,et al.  Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. , 1988, BMJ.

[9]  J. Neijt,et al.  Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. , 1987, The American journal of medicine.

[10]  P. Reitsma,et al.  A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's disease. , 1978, Advances in experimental medicine and biology.

[11]  J. Hermans,et al.  REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT , 1987, The Lancet.

[12]  I. Henderson,et al.  Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. , 1993, The American journal of medicine.

[13]  R. Rubens,et al.  Bone metastases and breast cancer. , 1985, Cancer treatment reviews.

[14]  P. Cornu,et al.  Treatment of bone metastases from breast cancer and myeloma with pamidronate. , 1991, European journal of cancer.